News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 217–252
- Matches
- 10012
- Sources here
- 14
- Companies here
- 34
Search results
Stored financial headlines
Active search
10012 matching headlines
Ticker or company: ZMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Pfizer (PFE) Faces Fresh Legal Questions, Does It Look Fully Valued?
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Pfizer (PFE) is back in focus after a new settlement program was announced for …
PFE
main company
PFE
main company
PFIZ34
main company
PFIZER
main company
PFE
main company
PFE
main company
+1 more
Sharemaestro market context
Price above Trend Line
52 weeks +22.2% · Next-week setup positive 56.8%
Halozyme Therapeutics (NASDAQ:HALO) CEO Sells 20,000 Shares of Stock
Halozyme Therapeutics CEO Helen Torley sold 20,000 shares of the company's stock for over $2 million, executed under a pre-arranged Rule 10b5-1 trading plan. This transaction reduced her holdings by 2.54%. The company recently exceeded analyst estimates with strong quarterly earnings and revenue growth, …
HALO
main company
Sharemaestro market context
Trend signal active
52 weeks +37.4% · Next-week setup positive 57.9%
Is Booz Allen Hamilton Holding (BAH) Still A Bargain After A 26% Slide?
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Booz Allen Hamilton Holding stock has erased around 26.2% over the past three years, yet the valuation checks still lean toward the shares …
BAH
main company
Sharemaestro market context
New activity signal
52 weeks -28.0%
J. Goldman & Co LP's AutoZone Inc(AZO) Holding History
This article details J. Goldman & Co LP's historical holdings in AutoZone Inc (AZO). As of June 30, 2026, J. Goldman & Co LP held 1,700 shares of AZO, valued at $5.43 million, representing 0.14% of their portfolio. The firm has made 9 purchases …
AZO
main company
Sharemaestro market context
Price below Trend Line
52 weeks -26.4% · Next-week setup positive 58.8%
Halozyme (NASDAQ: HALO) CEO sells tens of thousands of shares
Halozyme (NASDAQ: HALO) President and CEO Helen Torley exercised stock options and sold 60,000 common shares between August 17-19, 2026, under a pre-arranged Rule 10b5-1 trading plan. She exercised options at $18.41 per share and sold the shares in the high $90s to approximately …
HALO
main company
Sharemaestro market context
Trend signal active
52 weeks +37.4% · Next-week setup positive 57.9%
Amazon Makes Alexa+ Free on All Fire TV Devices — AI Agent Pricing Race to Zero
The subscription model for smart home AI just hit a significant roadblock. On August 19, 2026, Amazon announced it is dropping the $19.99 monthly fee for its advanced AI assistant, Alexa+, specifically for users on compatible Fire TV devices. As reported by TechCrunch and …
AMZN
main company
Sharemaestro market context
Trend signal active
52 weeks +14.8% · Next-week setup positive 56.3%
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Major Shareholder Group Walters Buys 4,335,000 Shares of Stock
Major shareholder Group Walters purchased 4,335,000 shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL) stock for $15.17 million, increasing their position by 32.09% to 17.84 million shares. This transaction occurred on August 14th, with the stock bought at an average price of $3.50 per share. Despite the …
ZNTL
main company
Sharemaestro market context
Trend signal active
52 weeks +78.9% · Next-week setup negative 44.0%
Citizens Financial Group Inc (CFG) Stock Down 3.7% but Still Overvalued -- GF Score: 70/100
Citizens Financial Group Inc (CFG) stock fell 3.7% to $70.76, remaining significantly overvalued by 36.1% according to its GF Value™ of $52.01. Despite a respectable GF Score™ of 70/100, concerns arise from its low financial strength, a P/E ratio above its historical median, and …
CFG
main company
Sharemaestro market context
Trend signal active
52 weeks +50.6% · Next-week setup positive 60.8%
Why Pfizer (PFE) Stock Is Trading Up Today
What Happened? Shares of global pharmaceutical company Pfizer (NYSE:PFE) jumped 3.8% in the afternoon session after positive clinical trial results from peers Merck and Moderna for an mRNA cancer treatment lifted sentiment across the pharmaceutical sector. The two companies reported that their mRNA cancer …
PFE
main company
PFE
main company
PFIZ34
main company
PFIZER
main company
PFE
main company
PFE
main company
Sharemaestro market context
Price above Trend Line
52 weeks +22.2% · Next-week setup positive 56.8%
Will AWS’s AI Surge and $220 Billion Capex Plan Change Amazon.com’s (AMZN) Narrative
In recent days, Amazon reported a past quarter in which AWS delivered its fastest growth in over four years, AI-related services inside AWS surpassed a US$25.00 billion annual revenue run rate, and management outlined around US$220.00 billion of 2026 capital spending focused on AI …
AMZN
main company
Sharemaestro market context
Trend signal active
52 weeks +14.8% · Next-week setup positive 56.3%
BZAI Investors Have Opportunity to Lead Blaize Holdings, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
The Rosen Law Firm reminds investors who purchased Blaize Holdings, Inc. (NASDAQ: BZAI) securities between July 18, 2025, and April 28, 2026, of the October 5, 2026, lead plaintiff deadline for a securities class action lawsuit. The lawsuit alleges that Blaize made false and …
BZAI
main company
Sharemaestro market context
Price below Trend Line
52 weeks -83.5% · Next-week setup negative 38.9%
Nearly one-fifth of Zentalis (NASDAQ: ZNTL) sits with one investor group
An amended Schedule 13G/A filing reveals that The Walters Group, associated with William T. Walters and Susan B. Walters, holds 18.8% of Zentalis Pharmaceuticals (NASDAQ: ZNTL) common stock. This significant ownership amounts to 17,844,973 shares out of 94,668,568 shares outstanding. The group reports shared …
ZNTL
main company
Sharemaestro market context
Trend signal active
52 weeks +78.9% · Next-week setup negative 44.0%
Walters Group acquires $15.17 million in Zentalis Pharmaceuticals stock
Walters Group, a 10% owner and director of Zentalis Pharmaceuticals Inc., acquired 4,335,000 shares of the company's common stock for $15.17 million at $3.50 per share. This transaction increases their total beneficial ownership to 17,844,973 shares, despite a recent decline in the stock, which …
ZNTL
main company
Sharemaestro market context
Trend signal active
52 weeks +78.9% · Next-week setup negative 44.0%
Zenas BioPharma (ZBIO) holder sells 673,755 shares in open-market trade
Zebra LP, an investor in Zenas BioPharma (ZBIO), sold 673,755 shares in an open-market transaction on August 19, 2026, at a weighted average price of $31.44 per share. This sale reduced their beneficial ownership to 4.98% of the company's common stock, below the 5% …
ZBIO
main company
Sharemaestro market context
Trend signal active
52 weeks +72.6% · Next-week setup positive 60.7%